Search Orphan Drug Designations and Approvals
-
| Generic Name: | cytomegalovirus specific cytotoxic T lymphocytes |
|---|---|
| Date Designated: | 01/05/2017 |
| Orphan Designation: | Treatment of cytomegalovirus infection in severely immunocompromised patients |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
ViraCyte, LLC 33 - 5th Avenue, NW Suite 700 New Brighton, Minnesota 55112 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







